G42 acquired a $100m-plus stake from existing investors in recent months through its 42XFund, Bloomberg reported
The listing is the latest in a series of IPOs in the Gulf region as governments seek to bring more international investors into their markets
G42 to propel the Mercedes-AMG Petronas F1 team with AI-powered, data-driven insights
The subscription period for the listing will open on October 21 and close on October 25
This is the first time G42 will appear as an exhibitor at Gitex to demonstrate the breadth of its technology ecosystem
The agreement will allow for automation of governance, risk management and compliance tasks, helping the government and private entities to become more secure
The G42 Expansion Fund’s investment priorities will span across computing and communications technologies, intelligent mobility, clean tech and renewables, digital infrastructures, fintech, healthcare and life sciences
The collaboration will see both companies accelerate the development of digital technologies to unlock greater value from oil and gas operations
Both companies will ensure alignment of their respective capabilities, expertise and resources that will facilitate solution planning and execution
The facility will focus on vaccine and therapeutic products to “strengthen regional supply chains”
Recent studies found that high-performance AI frameworks powered by GPUs can improve profitability by over 13 per cent in oil field planning scenarios
AI and data analytics have enabled the healthcare industry to rapidly respond to the pandemic says Hadi Anwar, group CIO of G42
Group 42 signed an agreement with Rafael to form Presight.AI and plans to establish a research and development center in Israel
The ‘Life Sciences and Vaccine Manufacturing in the UAE’ is a joint project by the Abu Dhabi-based Group 42 and China’s Sinopharm CNBG
The UAE reported its highest daily rise of Covid-19 case on January 6, equalling 2,067
Mubadala will integrate two of its entities, Injazat and Khazna, into G42
The target was achieved in less than a month with individuals from 107 nationalities participating in the programme
They will jointly leverage their combined knowledge, human and technological assets, to accelerate the delivery of solutions to combat the pandemic
If successful, the vaccine could enter the market by the end of 2020 or early 2021
The device which is expected to be available in the market over the next few months is developed by QuantLase Imaging Lab and will enable rapid mass-scale testing